Dendreon Corp fka DNDNQ

[stuck_holder]

no doubt they need cash, and the note offering (terms still to be negotiated) is a way for management to avoid up-front dilution, but the rest of their pipeline besides Provenge is so far away from potential commercialization that any positive developments in that regard will have a muted effect on price, imo.

unless i'm missing something, with no prospect for appeal, little prospect for partnership, i'm afraid the opportunity cost of holding for the next couple of years until 9902B results come in(with current management at the helm at least) will be high.

good luck to those who decide to hold on...i'm going to unstuck myself.